Dyadic Applied BioSolutions News and Activities

Dyadic Applied BioSolutions is a company listed under the stock ticker DYAI (US).

View the org chart displaying its 11 main executives

Most searched biographies at Dyadic Applied BioSolutions

• Mark Emalfarb, Chief Executive Officer and President
• Patrick Lucy, Chairman of the Board
• Seth Herbst, Director

Create your alert
to follow the executive moves at Dyadic Applied BioSolutions.

Dyadic Applied BioSolutions has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).
• NewLimit has just announced a $435 Million fundraising (posted on June 3 2026).
• Rallybio and Avenzo Therapeutics have announced they will merge  (posted on June 1 2026)..

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Valerie Hanote - Non-Executive Director at Eurofins

Learn more about the Biotechnology industry

Press releases by Dyadic Applied BioSolutions

• RSS Feed of Press Releases for DYAIDyadic to Report Third Quarter 2018 Financial Results on Wednesday, November 7, 2018Dyadic Announces Analyst Coverage Initiated by Zacks Small-Cap ResearchDyadic International to Present Thursday October 4, 2018 at 2:30
• Press Releases | Dyadic International, Inc :Dyadic International, Inc
• Dyadic International Improves Monoclonal Antibody (mAb) Productivity Utilizing C1 Gene Expression Platform to Manufacture Biologics | Dyadic International, Inc :Dyadic International, Inc

Social media about Dyadic Applied BioSolutions

• Dyadic Applied BioSolutions on Wikipedia, Google News & Yahoo Finance
• Dyadic Applied BioSolutions on LinkedIn, X (Twitter) & YouTube